A gel to prevent scar tissue after fibroid surgery
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This trial tests whether a gel placed in the uterus after fibroid removal reduces scar tissue (adhesions). It may help women who still want to become pregnant or have had trouble conceiving.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your BMI is between 18 and 35.
- You have at least one fibroid seen on ultrasound.
- This is your first surgery for fibroids or your first uterine surgery.
- You plan to have children in the future or have had trouble getting pregnant.
- You are not pregnant or breastfeeding.
- You do not have a history of uterine scar tissue or certain serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
This trial tests if giving misoprostol before surgery can reduce blood loss during the removal of uterine fibroids (non-cancerous growths). It is for women who need laparoscopic or open surgery for their fibroids.
This study looks at whether removing certain uterine fibroids (myomectomy) affects IVF outcomes. It may help doctors understand which fibroid patterns are most beneficial to treat before IVF.
This trial looks at ways to prevent scar tissue (intra-uterine adhesions) from forming after fibroid removal surgery. If you are having myomectomy, you may be helping test an approach that could protect the inside of your uterus.
This study tests a cross-linked hyaluronan gel placed in the uterus to help prevent painful or disruptive scar tissue (adhesions) after a procedure using ultrasound guidance. If you are eligible, the trial may help reduce the chance of future fertility and menstrual problems caused by scar tissue.
Hear when a new Myoma;Uterus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.